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Recent advances in high-throughput technologies have transformed methodologies employed to study cell-specific epigenomes
and the approaches to investigate complex cellular phenotypes. Application of next-generation sequencing technology in the
skeletal muscle diﬀerentiation field is rapidly extending our knowledge on how chromatin modifications, transcription factors
and chromatin regulators orchestrate gene expression pathways guiding myogenesis. Here, we review recent biological insights
gained by the application of next-generation sequencing techniques to decode the epigenetic profile and gene regulatory networks
underlying skeletal muscle diﬀerentiation.
1. Introduction
During developmental processes, in response to external
cues, changes in chromatin involving activation and repres-
sion of transcription factors and chromatin regulators (e.g.,
chromatin-modifying enzymes) underlie commitment of
specific cells to defined lineages. Importantly, transcription
factors and chromatin modifiers are also able to alter the
cellular expression program to maintain cell identity even
upon removal of the initiating diﬀerentiation stimuli [1].
During development and in adulthood, cellular identity is
established and maintained by finely tuned mechanisms of
gene repression and expression, preserved through rounds of
cell division. Diﬀerentiation processes are achieved by sculpt-
ing cell-specific epigenomes, which establish and maintain
cellular diversity [2]. Epigenetic information relies on several
elements, such as histone modifications, histone variants,
nucleosome accessibility, DNA methylation and hydrox-
ymethylation, and nuclear organization. These chromatin
states influence access of transcription factors and enzymes
to the underlying DNA [1].
2. Epigenetic Regulators of Myogenesis
Myogenic lineage commitment and execution of the terminal
diﬀerentiation program relies on the activity of the paired-
box transcription factors Pax3 and Pax7 and of the muscle
regulatory factors (MRFs) MyoD, Myf5, MRF4, and myo-
genin [3]. Myogenesis is a multistep process, which restricts
cell fate and commits cells to become skeletal muscle. During
embryonic development, myogenic precursor cells derived
from the somites express Pax3 and Pax3/Pax7 and are capable
of proliferation and self-renewal [4, 5].
In response to extrinsic signals, Pax3+ cells are com-
mitted to myoblasts and undergo terminal myogenic diﬀer-
entiation through the transcriptional network activated by
MRFs. During postnatal life, muscle growth relies on satellite
cells, which are a subpopulation of somite-derived cells that
reside between myofibers and the basal lamina [5]. Satellite
cells adopt a quiescent state, and upon environmental cues,
such as mechanical stress, injury or in pathological environ-
ment of degenerative muscle diseases, they are activated to
proliferate and terminally diﬀerentiate to regenerate muscle
[3]. Satellite cells encompass a population of cells that
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maintains the uncommitted state and another group of
cells that are committed to the myogenic lineage and will
undergo myogenic diﬀerentiation. Because of these two
distinct features, satellite cells are defined as bona fide adult
stem cells.
MRFs achieve the task of transcriptional activation
through the participation of nonmuscle restricted transcrip-
tional activators, such as the Mef2, Six, and Runx family
members [6]. The progressive elucidation of transcription
factors involved in myogenesis has revealed the strong
contribution of several epigenetic regulators of skeletal
muscle genes transcriptional activation: chromatin modifiers
such as histone acetyltransferases and a subset of his-
tone demethylases modify histones, promoting transcription
activation. Additionally, chromatin remodeling complexes
facilitate nucleosome mobility to favor the access of tran-
scription factors to chromatin regulatory regions. At the
onset of diﬀerentiation, histone acetyltransferases such as
p300 and PCAF are recruited to muscle specific genes by
myogenic bHLH, Mef2, and SRF proteins and exert their
enzymatic activity on regulatory chromatin regions and on
transcription factors such as MyoD [7, 8]. Moreover, the
WDR5/Ash2L/MLL2 complex is engaged to the chromatin of
Myf5 and myogenin genes by Pax7 and Mef2D, respectively,
to methylate histone H3 at lysine 4 and to stimulate
transcription activation [9, 10].
Moreover, other sets of epigenetic regulators exert their
function by repressing gene transcription: HDACs (e.g.,
SIRT1 and HDAC1/3/4/5) [8] and histone methylases such
as Suv39h1 and the Polycomb repressive complex 2 (PRC2)
complex are recruited at inactive muscle specific genes [3, 8].
Although HDACs role in regulating transcription has been
traditionally viewed as mutually exclusive to HATs function,
a novel model is emerging in which HDACs and HATs
cooccupy active genes [11]. HDACs task on transcribed
regions is to remove acetyl groups previously added by HATs
and to reset the chromatin modification state in preparation
of the next round of transcription. According to this model,
HATs and HDACs activities are interconnected by a dynamic
interplay in regulating gene transcription [11]. Although
further investigation at the genomewide level is warranted to
define HATs/HDACs interplay throughout myogenesis, the
knowledge that MyoD, PCAF, and the histone deacetylase
Sir2 are able to form a complex and associate with chromatin
[12] hints for a dynamic role of HATs and HDACs in
skeletal muscle specification and maintenance, as well as in
their nonhistone targets modulation. Polycomb group (PcG)
proteins are a set of proteins that play a prominent role in
the maintenance of cellular identity and in the regulation of
developmental genes. These specialized proteins assemble in
diﬀerent Polycomb Repressive Complexes (PRCs) that exert
their repressive function by establishing a nonpermissive
chromatin structure [13]. Ezh2, Suz12, and EED are the core
components of PRC2, which is responsible for the di- and
tri-trimethylation of histone H3 at lysine 27. This repressive
mark subsequently confers to chromatin the ability to recruit
the PRC1 complex that in turn catalyzes the ubiquitination
of histone H2A and further compacts chromatin [14, 15].
PcGs contribution to the preservation of cell identity is
achieved through the regulation of developmental genes
from diﬀerent lineages, both in embryonic and in lineage-
committed stem cells [16]. In embryonic stem cells, PRC2
localizes to chromatin regulatory loci of developmental
regulators often coexisting with H3K4 trimethylation, a
histone mark associated with a transcriptionally permissive
chromatin state [17–19].
Several lines of evidence showed that enhancer of Zeste
homolog 2 (Ezh2), the catalytic subunit of the PRC2 com-
plex, is recruited to a subset of muscle-specific promoters in
myoblasts [15, 20, 21] to prevent premature transcription,
and it is displaced from these loci throughout the diﬀeren-
tiation process. Furthermore, Juan et al. dissected the role of
PRC2 in skeletal muscle stem cells, by exploiting satellite cells
derived from mice with a Pax7-dependent Ezh2 deletion.
The authors conclude that Ezh2 is essential for satellite
cells self-renewal, proliferation, and cell identity. Deletion
of Ezh2 leads to increased levels of the cell cycle inhibitor
p16 (Cdkn2a), which aﬀects satellite cells proliferation rate.
Moreover, Ezh2-null satellite cells misexpress nonmyogenic
lineage genes, normally repressed by PRC2 in skeletal satellite
cells [22].
In summary, PcG role in satellite cells is to prevent
ectopic diﬀerentiation, thus maintaining quiescence and
proliferation states and safeguarding the mis-expression
of non-myogenic genes in skeletal muscle cells. Another
layer of control in myogenesis and muscle homeostasis
is exerted by microRNAs (miRNAs) and long noncoding
RNAs (lncRNAs) [23, 24]. miRNAs attenuate transcripts
level through translation repression or mRNA degradation.
Several miRNAs that modulate myogenesis have been shown
to impact numerous processes in various lineages, such as
miR-214 and miR-26a that target Ezh2 [25, 26]. Instead,
miR-1, miR-133, and miR206 are specifically expressed in
cardiac and skeletal muscle under the control of MyoD, SRF,
and Mef2C transcription factors, and they regulate satellite
cells proliferation and myoblast diﬀerentiation [23, 27, 28].
miR-208 and miR-499 are also specifically expressed in
muscle and constitute a family of intronic miRNAs, referred
to as “MyomiRs” [29]. These miRNAs are encoded by introns
of the myosin genes and regulate myofibers specification. In
addition, long noncoding RNAs (lncRNAs) are also emerging
as regulators of the myogenic diﬀerentiation program [24,
30, 31]. Among lncRNAs, competing endogenous RNAs
(ceRNAs) regulate miRNAs activity. Cesana et al., discovered
that the muscle-specific lncRNA linc-MD1 acts as a natural
decoy for miR-133 and miR-135, preventing them from
binding to Mef2C and Mastermind-like 1 mRNAs and thus
hampering miRNAs mediated negative eﬀect on protein
levels [24].
In this paper we will focus on recent findings depict-
ing the epigenetic landscape of myoblasts cells, obtained
through the application of Next Generation Sequencing
(NGS) technology. The most recent results presented by
three independent research groups shed new light on the
genomewide epigenome of myoblast cells, focusing on
histone modifications signature, the genomewide location of
the MyoD transcription factor and of chromatin modifiers,
for example, PcG proteins.
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3. The Next-Generation Sequencing
“Revolution”: Brief Overview of NGS-Based
Methods to Study Epigenomes
In recent years, high-throughput technologies have been
developed and rapidly improved to interrogate several
aspects of cellular processes. Likewise, traditional approaches
employed to interrogate the epigenome have undergone
profound transformation since their coupling to massive
parallel sequencing. As a result, approaches that investigated
restricted groups of genomic loci have been adapted to
genomewise analysis, with unprecedented resolution and
specificity, and with dramatically decreasing sequencing
costs.
Methodologies currently employed to investigate global
epigenetic signature are summarized in Table 1 and briefly
described as follows.
(i) 4C-Seq (circular chromosome conformation capture)
is used to map long-range chromatin interactions and relies
on proximity-based DNA ligation and sequencing of chro-
mosomal regions contacting a bait DNA region [32].
Hi-C-Seq is also employed to define chromosome archi-
tecture but it is free of bias for a bait locus [33].
(ii) ChIA-PET-Seq (chromatin interaction through
DNA-binding protein) combines chromatin immunoprecip-
itation (ChIP), proximity ligation, pair-end tag, and deep
sequencing to detect chromatin interactions mediated by a
protein, at the genomewide scale [34, 35].
(iii) MNase-Seq exploits the property of micrococcal
nuclease (MNase) to preferentially cleave linker region DNA
and the MNase-digested DNA can therefore be used to
annotate nucleosomes distribution [36]. DNase sequencing
on the other hand allows to map DNase I hypersensitive sites
on the genome and therefore to identify accessible chromatin
regions, which are not tightly compacted by nucleosomes
[37]. FAIRE-Seq (formaldehyde-assisted isolation of regula-
tory regions) describes regulatory sequences with a reduced
nucleosome content [38].
(iv) Chip sequencing (ChIP-Seq) couples the conven-
tional chromatin immunoprecipitation technique with mas-
sive parallel sequencing, and it is used to profile histone
modifications, andmap transcription factors, core transcrip-
tional machinery and chromatin modifiers recruitment in a
genomewide scale. The genomewide map of generated reads
provides information on the location and the intensity of the
protein-DNA interaction [19, 39].
(v) Bisulfite-Seq relies on the ability of bisulfite to
convert unmethylated cytosines to uracils so that massive
parallel sequencing can identify cytosine methylation status
at the single base pair resolution [40]. Alternatively, ChIP-
based methods can be employed to enrich for methylated
DNA, exploiting antibodies raised against 5-methylcytosine
(MeDIP-Seq) [41] or methylated DNA-binding proteins
(MBD-Seq) [42].
(vi) Furthermore, global mRNA expression profiling
can now be achieved through a deep-sequencing approach
(RNA-Seq) that sequences steady-state RNA (known and
novel ones) in a sample, oﬀering larger than microarrays
dynamic range and sensitivity. However, a gene list is not
the final step of this approach, deeper insight is gained by
bionformatics resources such as gene enrichment analysis,
pathways, and regulatory network analysis [43]. One key
advantage of RNA-Seq over methodologies employed in the
past is that it can profile mRNAs, lncRNA, and small RNAs
at the same time.
4. Interpreting Transcriptional
Regulation of Myogenesis
Exploiting Chip assays coupled to massive parallel sequenc-
ing, Cao et al. identified the genomewide binding of MyoD,
in C2C12 myoblast cells, satellite cells, and in mouse
embryonic fibroblasts (MEFs) converted to myotubes by
the stable expression of MyoD [44]. As predicted, MyoD
is recruited to E-boxes of genes regulated during skeletal
muscle diﬀerentiation. Unexpectedly, MyoD also constitu-
tively binds additional nonmyogenic loci, with a high density
of peaks in intergenic and intronic regions, in addition to
an enriched distribution in promoter regions. Of note, the
ChIP-Seq data presented show high concordance of results
obtained from C2C12 myoblasts cells, primary satellite cells,
and MEFs cells transduced with MyoD.
Most of MyoD bound regions regulate genes expressed
both in undiﬀerentiated C2C12 and diﬀerentiated myotubes,
while, in approximately 10% of MyoD targets, the binding is
associated with distinct peaks in myotubes versus proliferat-
ing cells. Therefore, MyoD constitutively binds the majority
of identified sites in both proliferating and diﬀerentiated
C2C12 cells. Most of MyoD binding sites do not represent
classical enhancer elements, since out of 25 MyoD bound
regions only 10 showed enhancer activity in a transient trans-
fection assay. Interestingly, MyoD broad binding throughout
the genome correlates with chromatin regions with overall
increase in their histone H4 acetylation levels in MyoD-
transduced MEF cells versus control cells. Conversely, MyoD
expression in MEF cells marginally impacts the distribution
of the H3K4me3 marks. Thus, MyoD may play a crucial role
in broadly reprogramming the epigenetic architecture of the
lineage-specified cells. The latter findings suggest that MyoD
association throughout the genome leads to the recruitment
of histone acetyltransferases and most likely of chromatin
remodeling factors [8], possibly independently of the local
transcriptional regulation of the target region. Moreover,
MyoD expressionmay deeply aﬀect nuclear organization and
genomic architecture. Early experiments in several cell lines
demonstrated thatMyoD is amaster regulator able to convert
certain cell types but not others to skeletal muscle [45, 46].
Therefore, MyoD ability to induce skeletal muscle-specific
transcripts expression in nonmyogenic lineages may rely
on its ability to associate a broad number of nonmyogenic
target genes and to coordinate a broad reconfiguration of
chromatin states. Further Hi-C-Seq experiments in MEF
cells converted by MyoD overexpression and control MEF
cells may reveal global spatial reorganization of the genome,
triggered by MyoD-forced expression. Furthermore, ChIA-
PET experiments may reveal MyoD-mediated long-range
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Table 1
Method Method description Genomewide data Reference
4C-Seq,
Hi-C-Seq
Chromatin proximity ligation and sequencing
3-Dimensional protein-DNA interaction
Long-range chromatin interaction DNA looping
[23, 24]
ChIA-PET
Chromatin interaction analysis with paired-end tag
sequencing: ChIP enrichment followed by chromatin
proximity ligation and sequencing
Long-range chromatin interactions mediated by a DNA
binding protein
DNA looping
[25, 26]
DNase-Seq Sequencing of DNaseI-digested DNA fragments
Chromatin accessibility and nucleosome positioning
Identification of nucleosome-free regulatory regions
[28]
FAIRE-Seq
Formaldehyde-assisted isolation of regulatory elements
sequencing
Chromatin accessibility
Genome-wide mapping of protein-free DNA
[29]
MNase-Seq Sequencing of micrococcal nuclease-digested DNA
Genomewide mapping of nucleosome-protected DNA
nucleosome positioning
[27]
ChIP-Seq
Sequencing of DNA fragments obtained from
chromatin immunoprecipitation assays
Genomewide mapping of protein-DNA interactions
(a) Histone posttranslational modifications
(b) Histone variants
(c) Transcription factors
(d) Chromatin modifiers and remodelers
[19, 30]
BS-seq BS-Seq: bisulfite sequencing DNA methylation [31]
MeDIP-seq
MeDIP-Seq: methylated DNA immunoprecipitation
sequencing
DNA methylation [32]
MBD-seq ChIP with methylated DNA-binding proteins DNA methylation [33]
RNA-Seq Sequencing of RNA
Expression profiling
Noncoding RNA expression
Novel transcripts
Alternative splicing
[34]
chromatin interactions [34, 35] and disclose how MyoD
aﬀects topological myoblast architecture.
5. HistoneModifications Signature in
Myoblasts andMyotubes
Asp et al. performed an initial comprehensive description
of myoblasts and myotubes histone modifications profile
[47]. The authors exploited the Chip technique coupled
to massively parallel sequencing (ChIP-Seq) to identify the
genomewide distribution of epigenetic marks and RNA
polymerase II (RNA PolII). Data fromChIP-Seq experiments
were merged with expression profiles data to depict a first
portrait of epigenetic landscape changes underlying C2C12
myoblasts diﬀerentiation. The authors provide evidence
that histone H3 acetylation at lysines 9 and histone H4
acetylation at lysine 12 are dramatically decreased on chro-
matin regions of diﬀerentiating myotubes, while H3K18Ac
levels are reduced on constitutively active genes and on
genes whose expression decreases in myotubes. Furthermore,
promoters of genes upregulated in myotubes prematurely
show enriched recruitment of RNA PolII and histone marks
correlating with transcriptional activation in proliferating
myoblasts, suggesting that they already acquire features of
active chromatin, before they reach their maximal expression
levels. In addition, the authors focus their attention on
genes silenced both in myoblast and myotubes. Histone
H3K27me3 is largely found in promoters, gene bodies,
and intergenic regions. Genes marked by H3K27me3 show
inverse correlation with RNA PolII recruitment. Genes
marked by H3K27me3 modification can be divided into two
classes: one group of genes displays H3K27me3 mark in
undiﬀerentiated state and is corresponding to a gene ontol-
ogy (GO) category of genes essential for muscle formation.
Consistent with previous studies [15, 22], a significant subset
of these genes exhibits a reduction in H3K27me3 mark upon
diﬀerentiation. Nevertheless, another subset of genes in this
cluster is transcriptionally upregulated and is capable to
maintain the H3K27me3 mark throughout diﬀerentiation.
Furthermore, genes involved in nonmuscle lineage com-
mitment can be grouped in a distinct cluster characterized
by the H3K27me3 mark and a transcriptionally silent state,
both inmyoblasts andmyotubes. Notably, mesoderm-related
genes, such as genes involved in myogenesis, adipogenesis,
and osteogenesis are not present in this cluster. Interestingly,
as shown for other lineage committed cells [18], only a small
fraction (11%) of H3K27me3 genes displays a bivalent mark
in myoblasts.
Because every cell lineage displays a specific genomewide
profile of histone modifications, a comprehensive descrip-
tion of the chromatin signature of skeletal muscle cells
will represent a precious resource for scientists investigating
mechanisms underlying myogenic transcriptional regula-
tion.
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6. ChromatinModifiers: Contrasting Roles of
PcG Proteins inMyogenesis
Genomewide mapping of chromatin factors has provided
insights into the gene networks regulated by histone acetyl-
transferases, HDACs, and chromatin modifiers in ESCs and
hematopoietic lineages [11, 48], which have been cellular
systems at the forefront in the application of next-generation
sequencing technologies (NGS). More recently, Mousavi
et al. employed ChIP-Seq to investigate the genome-wide
occupancy of chromatin modifiers belonging to the PcG
proteins in skeletal muscle cells and explored their relation
to RNA Polymerase II recruitment and the distribution
of the opposing histone marks H3K27me3 and H3K4me3
[49]. As anticipated, Ezh2 recruitment substantially overlaps
with the H3K27me3 marked genes in C2C12 myoblasts.
Unexpectedly, Ezh1, an Ezh2 paralog that has been shown
to have overlapping transcriptional repressive function in
ESCs [50, 51], showed overlap with only 14% of H3K27me3
marked genes. Conversely, 51% of the regions occupied
by Ezh1 are found to be associated with H3K4me3.
Comparison of RNA-Seq profiles and RNA polymerase II
global recruitment reveals that Ezh1 enriched regions are
located on actively transcribed loci. Chip-Seq experiments
with antibodies recognizing the elongating form of RNA
Pol II (Phospho-serine-2 RNA Pol II) and a marker of
elongation (H3K36me3) in Ezh1-depleted cells revealed that
Ezh1 promotes RNA transcription, regulating the elongation
step. Thus, genomewide mapping analysis unveiled a novel
function for a member of PcG proteins, during the myogenic
diﬀerentiation process.
7. Deep Sequencing Technologies and the Study
of Skeletal Muscle Diseases
NGS technologies open novel avenues in the study of
myopathies: the newmethodological approach will shed new
light on the biological pathways involved in skeletal muscle
diseases and become an essential tool to study genetic causes
of myopathologies. Furthermore, it will likely become a
valuable technological approach in molecular diagnosis [52].
A recent report by Geng et al. highlights the role of ChIP-
Seq technology in revealing the molecular pathways mod-
ulated by the homeobox protein DUX4, a candidate gene
misexpressed in facioscapulohumeral dystrophy (FSHD)
[53]. The authors performed chromatin immunoprecipi-
tation assay followed by high-throughput sequencing in
human skeletal myoblasts overexpressing the isoform of
DUX4 (DUX4-fl) detectable in FSHD but not in control
muscles. The set of genes identified as misregulated in
DUX4-overexpressing cells has been also deregulated in
FSHD skeletal muscle but not in control tissues, and
this finding led authors to the identification of candidate
pathways contributing to a better understanding of the
disease etiology. Furthermore, this set of genes represents
promising biomarkers to design novel diagnostic and treat-
ment strategies.
NGS approaches may also represent a suitable diag-
nostic tool for Duchenne and Becker muscular dystrophy,
because of the heterogeneity in the mutational spectrum
of the disease and the large size of the dystrophin gene
[52]. Therefore, NGS-rooted technologies may not only be
invaluable in the discovery of human disease genes but also
represent an important avenue to be pursued in molecular
diagnosis of myopathies in particular, as NGS protocols have
been recently extended to analyze clinical samples that are
formalin-fixed and paraﬃn-embedded [54].
8. Conclusions and Perspectives
Comprehensive understanding of the myoblast/myotube
epigenome will extend our fundamental knowledge of
molecular mechanisms orchestrating biological processes,
such as myogenic diﬀerentiation, muscle development,
maintenance, and regeneration, in physiological and myo-
pathological conditions. Deep sequencing methodologies
will assist stem cell research toward the comprehension of
mechanisms underlying muscle cells identity. This knowl-
edge has important implication for regenerative medicine,
underscoring new paradigms for satellite cells biology and
oﬀering novel targets of pharmacological intervention.
Recent advances in NGS technology allow address-
ing several epigenetic questions at the genomewide scale
(Figure 1). To date, a restricted number of epigenetic regula-
tors of myogenesis have been examined exploiting RNA-Seq
and ChIP-Seq approaches. Although we predict that addi-
tional studies are underway, further studies are warranted to
define global transcriptional targets and genomewide bind-
ing sites of transcription factors that modulate myogenesis
(e.g., Pax7, Myf5, Myogenin, Mef2, SRF). A comprehensive
description of their transcription targets and regulatory
elements will define how individual transcription factors
are connected to gene regulatory networks and how they
influence each other at the genome level.
Characterization of the histone modifications landscape
in skeletal muscle cells can be exploited further to anno-
tate lineage-specific functional genomic elements, such as
enhancers and insulators [55–57]. Chromatin profiling can
therefore become a predictive means to define regulatory
regions that are selectively functional, poised, or non-
functional in myoblasts and myotubes or throughout mouse
development. Moreover, the application of 4C/Hi-C-Seq
technology and ChIA-PET in skeletal muscle cells that
undergo diﬀerentiation will provide structural information
on chromosomes long-range chromatin interactions and
chromatin compartmentalization within the nucleus.
Potential drawbacks of NGS techniques are the amount
of starting material that frequently is a limiting factor. Isola-
tion of quiescent satellite cells by cell sorting greatly reduces
the number of cells one can use for RNA-Seq or ChIP-
Seq experiments. Nevertheless, new protocols for chromatin
immunoprecipitation assays coupled with massively parallel
sequencing have been developed and optimized for lim-
iting sample material [58]. Furthermore, third-generation
sequencing platforms are now designed to sequence DNA at
the single molecule and have already been used in proof of
principle epigenetic studies [59].
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Figure 1: During development and muscle regeneration, satellite cells exit quiescence, actively proliferate, and terminally diﬀerentiate and
fuse to form new muscle fibers. Within the nucleus, these steps are finely tuned by modifications in high-order chromatin structures and
nucleosome accessibility, by changes in protein complexes recruited at regulatory regions, by alterations in histones marks and in the DNA
methylation state. NGS oﬀers invaluable means to explore each of these variations genomewide and to accurately identify pathways and
regulatory networks underlying satellite cells activation and diﬀerentiation.
Another challenge introduced by NGS technology is the
growing need for bioinformatics tools to analyze the vast
amount of data generated by each experiment. Moreover,
large-scale data obtained from NGS platforms need to be
made available to the broad scientific community in a
standardized and simple annotation form, as these data
represent a precious framework to infer biological informa-
tion. Bioinformatics pipelines require further refinements to
enable expansion ofmapping capabilities to the genome [60],
improve normalization within and between samples to avoid
high number of false positive diﬀerential results [61] and to
better correlate results of ChIP-Seq, RNA-Seq, and whole-
genome DNA methylation analysis at the single-nucleotide
resolution.
Besides implementing computational methods in bio-
logical studies, successful application of NGS technologies
imposes a more profound revolution related to experimental
design and forces a transition from single-gene hypothesis-
driven experiments to a genomewide view, in which under-
standing of the integration and the cross-talk of diﬀerent
circuitries is at the forefront. The achievements of these
remarkable research capabilities lie in the combination of
conventional molecular and cellular biology approaches with
a systemwide genetic view, which enables us to explore
so far not addressable questions and will help us to gain
a more comprehensive insight into mechanisms guiding
skeletal muscle cells during diﬀerentiation, its maintenance
and response to pathological insult.
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